In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CoreValve: A Surgeon Moves Heart Valves to the Cath Lab

Executive Summary

Heart valve replacement and repair has long been the exclusive province of surgeons. The percutaneous heart valve sector, including both aortic and mitral, has been among the hottest device areas for investors and entrepreneurs over the past few years. CoreValve was founded b a surgeon who is using his understanding of valve anatomy to develop a percutaneous aortic valve replacement (PAVR) device that can be used by interventional cardiologists.
Advertisement

Related Content

Device Companies Look West, East, Anyplace But US
Medtronic: Doing Just What the Doctors Order
Abbott Moves into Heart Valves with Evalve Deal
A New Chapter for Device VCs
Heart Valve Market: PAVR Poised for Growth
Device Exits Can Rival Biotech, But Watch Out for the Risks
Stentys SAS
JenaValve Technology GMBH
EuroPCR Highlights: CoStar Fizzles, Xience Sizzles
In Heart Valves, a Brave, New, Non-Surgical World

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002910

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel